New Horizons in Treating Hypertrophic Cardiomyopathy: Practice Changing Molecules and Data
Cardiac myosin inhibitors: how do they work, and how could they improve your management of patients with hypertrophic cardiomyopathy (HCM)? Our experts discuss the latest data!
Authors: Theodore Abraham, MD, FACC, FASE; Sara Saberi, MD, MS; Anjali Owens, MD
All Credits Available
Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™
Nurses - 1.25 ANCC Contact Hour(s) (1.25 contact hours are in the area of pharmacology)
Pharmacists - 1.25 Knowledge-based ACPE (0.125 CEUs)
Click "Proceed" to be taken to the Medscape site.
CME / CE Released:
11/3/2022
Valid for credit through:
11/3/2023
Claim your credit at the Medscape site.
See More at
New Horizons in Treating Hypertrophic Cardiomyopathy: Practice Changing Molecules and Data